Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest announcement is out from Imunon ( (IMNN) ).
Imunon, Inc. has appointed Susan Eylward as its new General Counsel and Corporate Secretary, effective October 7, 2024, with a starting salary of $340,000 and eligibility for a 30% annual performance bonus. Eylward brings extensive experience in legal matters from her previous roles at companies like Science 37, Inc., Allstate Corporation, and National General Holdings Corp. To incentivize her employment, Imunon granted Eylward an option to purchase 50,000 shares of common stock, with a 10-year term and a four-year vesting schedule, under the Nasdaq Listing Rule 5635(c)(4). The company’s current projects include a DNA-based immunotherapy for ovarian cancer and a COVID-19 booster vaccine.
For a thorough assessment of IMNN stock, go to TipRanks’ Stock Analysis page.
